[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@endpts Avatar @endpts Endpoints News

Endpoints News posts on X about sanofi, rates, $10m, seed funding the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence stocks finance vc firms technology brands

Social topic influence sanofi, rates, $10m, seed funding #259, admin, 10m, interactions, white house, $350m, eli lilly

Top assets mentioned Sanofi (SNY) Eli Lilly and Company (LLY) Agios Pharmaceuticals, Inc. (AGIO)

Top Social Posts #

Top posts by engagements in the last XX hours

"Bristol Myers' next-gen blood cancer treatment has cut rates of detectable cancer cells. Could it get accelerated FDA approval"
X Link @endpts 2025-09-23T17:52Z 30.6K followers, 1152 engagements

"How does Outcomes AI plan on using $10M seed funding to cut down nursing costs By having AI voice agents handle routine scheduling and follow-up interactions and supporting human nurses with AI-powered admin tools"
X Link @endpts 2025-10-14T18:28Z 30.6K followers, 1174 engagements

"AstraZeneca scores a win in its mid-stage trial for its hypertension candidate"
X Link @endpts 2025-10-07T19:32Z 30.6K followers, 1269 engagements

"AstraZeneca expected to announce MFN deal with White House Friday evening"
X Link @endpts 2025-10-10T17:12Z 30.6K followers, 1212 engagements

"Lila Sciences closed a $350M Series A to advance its AI-doing-science vision connecting models to experiments to create scientific superintelligence"
X Link @endpts 2025-10-14T20:57Z 30.6K followers, 1199 engagements

"Former FDA biologics chief Peter Marks is joining Eli Lilly as SVP for molecule discovery and head of infectious diseases months after his CBER exit"
X Link @endpts 2025-10-08T16:00Z 30.6K followers, 1076 engagements

"In this week's Peer Review: GSK CEO will hand the keys to commercial chief on Jan 1.; Astellas axed Chief Digital Officer position; and Oz Azam takes over as Cue Biopharma's CEO. Read the full rundown of this week's biggest job news:"
X Link @endpts 2025-10-03T11:47Z 30.6K followers, 1206 engagements

"$AGIO shares fell XX% after the FDA delayed its decision on Agios Pyrukynd for thalassemia to Dec. X citing review of a liver safety plan following two patient liver events in a trial"
X Link @endpts 2025-09-04T19:52Z 30.6K followers, 1247 engagements

"In Focus: Amgens David Reese traded his R&D role to lead its AI revolution. He calls it biotechs hinge moment and Endpoints @AndrewE_Dunn got an inside look"
X Link @endpts 2025-10-08T17:03Z 30.6K followers, 1488 engagements

"Sanofi and Orano Meds radiopharma AlphaMedix met both primary endpoints in Phase X for a rare type of cancer suggesting tumor shrinkage and prolonged benefits"
X Link @endpts 2025-10-08T15:08Z 30.6K followers, 2086 engagements

"Bristol Myers and insitro have extended their research deal to find a new drug to treat ALS Endpoints News has learned exclusively"
X Link @endpts 2025-10-14T13:20Z 30.6K followers, 1231 engagements

"🎙 Join us LIVE today at 2pm ET🎙 @vijaypande will sit with @AndrewE_Dunn to discuss life after a16z and what's next with AI in the bio world"
X Link @endpts 2025-10-07T11:46Z 30.6K followers, 1021 engagements

"EVOQ Therapeutics signed a deal worth up to $500M with Sanofi to advance its Treg-targeting autoimmune tech"
X Link @endpts 2025-10-16T14:39Z 30.6K followers, XXX engagements

"Cartography raised $67M in part from Pfizer and Amgens VC arms to launch its first trial mapping a path for its T cell engager in colorectal cancer"
X Link @endpts 2025-10-02T15:12Z 30.6K followers, 1160 engagements

"Genmab bets on its head and neck cancer pipeline with $8B acquisition of of Merus a Dutch biotech with a promising bispecific antibody"
X Link @endpts 2025-09-29T13:58Z 30.6K followers, 1109 engagements

"Novo Nordisk spending $4.7B to buy MASH specialist Akero"
X Link @endpts 2025-10-09T14:36Z 30.6K followers, 1051 engagements

"Legend Biotech is ramping up Carvykti production as it eyes blockbuster status in 2025 following $963M in sales last year"
X Link @endpts 2025-03-12T16:05Z 30.6K followers, XXX engagements

"Excellergy has high ambitions to treat allergies and inflammation. Its experimental drugs "effector cell response inhibitors ECRIs for shortcould treat anything from food allergies to eczema"
X Link @endpts 2025-10-13T19:51Z 30.6K followers, 1528 engagements

"Bristol Myers has entered the in vivo CAR-T race: the giant has announced it'll acquire Orbital Therapeutics for $1.5B cash"
X Link @endpts 2025-10-10T17:06Z 30.6K followers, 1071 engagements

"Novo Nordisk has shut down its research into cell therapies as part of its ongoing restructure"
X Link @endpts 2025-10-13T15:58Z 30.6K followers, 1242 engagements